Abiomed, Inc.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous…
Medical - Devices
US, Danvers [HQ]
ABMD/Financial Reporting
Income Statements
13 Sheets · Starting from 2010In Million USD. Margins, Growth Rates In %
| Metric | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 85.00 | 101.00 | 126.00 | 158.00 | 183.00 | 230.00 | 329.00 | 445.00 | 593.00 | 769.00 | 840.00 | 847.00 | 1,031.00 | |
|
EPS
|
-0.52 | -0.32 | 0.04 | 0.38 | 0.19 | 2.80 | 0.90 | 1.21 | 2.54 | 5.77 | 4.49 | 5.00 | 3.00 | |
| Diluted in mil. | -0.52 | -0.32 | 0.04 | 0.37 | 0.18 | 2.65 | 0.85 | 1.17 | 2.45 | 5.61 | 4.43 | 4.94 | 2.98 | |
|
Profit
|
63.00 | 79.00 | 101.00 | 126.00 | 146.00 | 190.00 | 279.00 | 374.00 | 495.00 | 639.00 | 689.00 | 685.00 | 843.00 | |
| Gross Margin | 73.72 | 78.27 | 80.61 | 80.02 | 79.68 | 82.66 | 84.70 | 84.14 | 83.40 | 83.16 | 82.01 | 80.90 | 81.76 | |
| Pre Tax | -18.00 | -10.00 | 2.00 | 16.00 | 8.00 | 28.00 | 65.00 | 91.00 | 160.00 | 263.00 | 256.00 | 288.00 | 190.00 | |
| Profit Margin | -21.41 | -10.74 | 2.01 | 10.66 | 4.64 | 12.49 | 19.98 | 20.51 | 27.02 | 34.23 | 30.54 | 34.01 | 18.47 | |
| ETR | -3.66 | -8.21 | 41.21 | 10.96 | 13.82 | -295.23 | 42.06 | 42.94 | 30.08 | 1.65 | 20.95 | 21.75 | 28.37 | |
| Net | -19.00 | -11.00 | 1.00 | 15.00 | 7.00 | 113.00 | 38.00 | 52.00 | 112.00 | 259.00 | 203.00 | 225.00 | 136.00 | |
| Profit Margin | -22.19 | -11.62 | 1.18 | 9.50 | 4.00 | 49.36 | 11.58 | 11.70 | 18.89 | 33.66 | 24.14 | 26.61 | 13.23 | |
| EBITDA | -26.00 | -7.00 | 4.00 | 19.00 | 10.00 | 31.00 | 67.00 | 94.00 | 164.00 | 230.00 | 257.00 | 246.00 | 400.00 | |
| EBITDA Margin | -31.38 | -7.47 | 3.82 | 12.19 | 5.86 | 13.56 | 20.63 | 21.29 | 27.70 | 29.99 | 30.62 | 29.14 | 38.84 | |
| Operating Income | -25.00 | -11.00 | 1.00 | 16.00 | 8.00 | 28.00 | 65.00 | 90.00 | 157.00 | 224.00 | 249.00 | 229.00 | 372.00 | |
| Operating Margin | -29.26 | -11.06 | 1.20 | 10.46 | 4.55 | 12.45 | 19.76 | 20.24 | 26.47 | 29.22 | 29.64 | 27.09 | 36.12 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 49.00 | |
| Loss | -110.00 | -112.00 | -124.00 | -141.00 | -175.00 | -201.00 | -264.00 | -355.00 | -436.00 | -544.00 | -591.00 | -617.00 | -775.00 | |
| Cost of Revenue | -22.00 | -21.00 | -24.00 | -31.00 | -37.00 | -39.00 | -50.00 | -70.00 | -98.00 | -129.00 | -151.00 | -161.00 | -188.00 | |
|
Operating Expenses
|
-88.00 | -90.00 | -100.00 | -109.00 | -137.00 | -161.00 | -214.00 | -284.00 | -338.00 | -415.00 | -440.00 | -456.00 | -586.00 | |
| R&D | -25.00 | -26.00 | -27.00 | -25.00 | -30.00 | -35.00 | -49.00 | -66.00 | -75.00 | -93.00 | -98.00 | -121.00 | -163.00 | |
| G&A | -60.00 | -62.00 | -71.00 | -84.00 | -107.00 | -125.00 | -164.00 | -218.00 | -262.00 | -321.00 | - - | - - | - - | |
| SG&A | -60.00 | -62.00 | -71.00 | -84.00 | -107.00 | -125.00 | -164.00 | -218.00 | -262.00 | -321.00 | -341.00 | -334.00 | -423.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | -4.00 | -3.00 | -4.00 | -2.00 | -2.00 | -2.00 | -3.00 | -6.00 | -11.00 | -14.00 | -20.00 | -24.00 | -28.00 | |
| Interest Expenses | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -49.00 | |
| Other Expenses | -6.00 | - - | -1.00 | - - | - - | - - | - - | -1.00 | -3.00 | -38.00 | -7.00 | -58.00 | -182.00 | |
|
WA Shares Outstanding
|
36.00 | 37.00 | 38.00 | 39.00 | 39.00 | 40.00 | 42.00 | 43.00 | 44.00 | 44.00 | 45.00 | 45.00 | 45.00 | |
| Diluted | 36.00 | 37.00 | 40.00 | 41.00 | 41.00 | 42.00 | 44.00 | 44.00 | 45.00 | 46.00 | 45.00 | 45.00 | 45.00 |